CI vs USBC
Cigna Corp (CI) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
CI currently screens at market cap $71.62B and trailing P/E 2.4. USBC currently screens at market cap $0.
Not investment advice. Open the CI and USBC stock pages for the full models.
Not investment advice.